Caspofungin resistance in clinical Aspergillus flavus isolates

Area of Science:

• Mycology
• Antifungal Resistance
• Molecular Biology

Background:

• Aspergillus flavus is an opportunistic fungal pathogen.
• Caspofungin (CAS) is a key antifungal agent used to treat invasive fungal infections.
• Emerging CAS resistance in A. flavus poses a significant clinical challenge.

Purpose of the Study:

• To identify candidate genes contributing to caspofungin resistance in clinical A. flavus isolates.
• To investigate the genetic mechanisms underlying CAS resistance in A. flavus.

Main Methods:

• Antifungal susceptibility testing of CAS on 14 clinical A. flavus isolates.
• FKS1 gene sequencing to detect mutations in resistant isolates.
• Complementary DNA-amplified fragment length polymorphism (cDNA-AFLP) to identify differentially expressed genes.
• Quantitative real-time PCR (qRT-PCR) to validate gene expression levels.

Main Results:

• No mutations were found in the FKS1 gene hot spot regions of resistant isolates.
• cDNA-AFLP identified several differentially expressed genes in CAS-resistant isolates.
• qRT-PCR revealed down-regulation of P-type ATPase and ubiquinone biosynthesis methyltransferase COQ5 in resistant isolates.

Conclusions:

• P-type ATPase and COQ5 may play a role in CAS resistance in A. flavus.
• Differential gene expression contributes to fungal survival under CAS exposure.
• Further studies, including gene overexpression and knockout experiments, are recommended to confirm the role of these genes in CAS resistance.